The spinal interbody market is expected to hit $2.5 million by 2030, according to a June 7 report. Advancements in spinal surgery technology, increased demand and adoption of minimally invasive surgery are all factors attributed to the projected 2.9 percent growth.
Metal-based implants have more than 45 percent of revenue share in the market and are growing at the highest rate. Factors include the flexibility, robustness and durability of metal-based implants.
Key players in the interbody device market include NuVasive, Medtronic, Stryker and Zimmer Biomet.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
